2.0
May 19, 2026
Former employee, more than 3 years
Pune
Recommend
CEO approval
Business Outlook
Pros
Good infrastructure in R&D, manufacturing, robust compliance set up.
Cons
Compared to Pharma biologics seems weak. Long timelines from inception to market delivery. In comparison, other Indian biosimilar sponsors have gone far ahead.